Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma

• DOI: 10.1016/j.xcrm.2023.101177
• Publication Date: 2023-08-30T14:35:54Z
• Authors: Yiyun Chen; Ran Huo; Weirong Kang; Yuwei Liu; Zheng Zhao; Weilun Fu; Ruochen Ma; Xiaomeng Zhang; Jihong Tang; Zhihan Zhu; Qingyang Lyu; Yi Huang; Mengli Yan; Biaobin Jiang; Ruichao Chai; Zhaoshi Bao; Zheng Hu; Weiping Wang; Tao Jiang; Yong Cao; Jiguang Wang
• Keywords: ErbB Receptors; 616; Tumor Microenvironment; Humans; Brain; Glioma; Glioblastoma; Article; Monocytes

The role of brain immune compartments in glioma evolution remains elusive. We profile immune cells in glioma microenvironment and the matched peripheral blood from 11 patients. Glioblastoma exhibits specific infiltration of blood-originated monocytes expressing epidermal growth factor receptor (EGFR) ligands EREG and AREG, coined as tumor-associated monocytes (TAMo). TAMo infiltration is mutually exclusive with EGFR alterations (p = 0.019), while co-occurring with mesenchymal subtype (p = 4.7 × 10-7) and marking worse prognosis (p = 0.004 and 0.032 in two cohorts). Evolutionary analysis of initial-recurrent glioma pairs and single-cell study of a multi-centric glioblastoma reveal association between elevated TAMo and glioma mesenchymal transformation. Further analyses identify FOSL2 as a TAMo master regulator and demonstrates that FOSL2-EREG/AREG-EGFR signaling axis promotes glioma invasion in vitro. Collectively, we identify TAMo in tumor microenvironment and reveal its driving role in activating EGFR signaling to shape glioma evolution.